INFORMATION CENTER

Our support agents are here to answer your questions at any time. You can either e-mail us at info@virotherapy.com or leave your query on the website and we will contact you.

FIND OUT IF VIROTHERAPY CAN HELP YOU

*Your request may be directly forwarded to a specialised clinic or doctor for quality assessment.


RECENT CLINICAL PUBLICATIONS



4-Week repeated dose rat GLP toxicity study of oncolytic ECHO-7 virus Rigvir administered intramuscularly with a 4-week recovery period

Read more


Clinical landscape of oncolytic virus research in 2020

Read more


The Oncolytic Virus in Cancer Diagnosis and Treatment

Read more


A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report

Read more


Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report

Read more


Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir

Read more


Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines

Read more


ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report

Read more


Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir.

Read more


Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient.

Read more


A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir®

Read more


Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are approved. The first, Rigvir, is an immunomodulator with anti-tumour effect

Read more


Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery

Read more


Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro

Read more


Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report

Read more


Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports

Read more


Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumor in a retrospective study

Read more




WATCH VIDEO


How does Oncolytic Virotherapy works?



About International Virotherapy Center


CANCER VIROTHERAPY JOURNAL



Address
The Greens Damac Smart Heights,
23rd Floor, Barsha Heights
P.O.Box 393578, Dubai, UAE
+971 42 757 419 (UAE)

Contact Us
info@virotherapy.com
+1 202 76 95 306 (Whatsapp )
+44 20 3868 4002 (UK)
+1 646 88 33 419 (USA)


© 2021 International Virotherapy Center Limited. All Rights Reserved